• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1% Δ9-四氢大麻酚滴眼液在人眼中的多点研究。

Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes.

作者信息

Jay W M, Green K

出版信息

Arch Ophthalmol. 1983 Apr;101(4):591-3. doi: 10.1001/archopht.1983.01040010591012.

DOI:10.1001/archopht.1983.01040010591012
PMID:6301412
Abstract

Twenty-eight male volunteers were given either 1% delta 9-tetrahydrocannabinol (delta 9-THC) or vehicle alone (light mineral oil). They used the medication four times per day for one week. Five volunteers, four of which used vehicle alone, discontinued the study because of burning sensation and lid swelling. In the 23 volunteers who completed the study, there was no difference in intraocular pressure between eyes treated with 1% delta 9-THC and controls.

摘要

28名男性志愿者被给予1%的Δ9-四氢大麻酚(Δ9-THC)或单独给予赋形剂(轻质矿物油)。他们每天使用该药物4次,持续一周。5名志愿者(其中4名仅使用赋形剂)因烧灼感和眼睑肿胀而退出研究。在完成研究的23名志愿者中,接受1%Δ9-THC治疗的眼睛与对照组眼睛之间的眼压没有差异。

相似文献

1
Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes.1% Δ9-四氢大麻酚滴眼液在人眼中的多点研究。
Arch Ophthalmol. 1983 Apr;101(4):591-3. doi: 10.1001/archopht.1983.01040010591012.
2
Ocular effects of topical administration of delta 9-tetrahydrocannabinol in man.δ9-四氢大麻酚经皮给药对人体的眼部影响。
Arch Ophthalmol. 1982 Feb;100(2):265-7. doi: 10.1001/archopht.1982.01030030267006.
3
Topical delta 9-tetrahydrocannabinol and aqueous dynamics in glaucoma.局部应用的 Δ9-四氢大麻酚与青光眼患者的房水动力学
J Clin Pharmacol. 1981 Aug-Sep;21(S1):467S-471S. doi: 10.1002/j.1552-4604.1981.tb02626.x.
4
Interaction between delta-9-tetrahydrocannabinol and indomethacin.δ-9-四氢大麻酚与吲哚美辛之间的相互作用。
Ophthalmic Res. 2001 Jul-Aug;33(4):217-20. doi: 10.1159/000055673.
5
Effect of delta 9-tetrahydrocannabinol on intraocular pressure after removal of autonomic input.9-四氢大麻酚对自主神经输入去除后眼压的影响。
J Ocul Pharmacol. 1985 Spring;1(1):47-57. doi: 10.1089/jop.1985.1.47.
6
Topical verapamil and episcleral venous pressure.局部用维拉帕米与巩膜静脉压
Ophthalmology. 1998 Dec;105(12):2251-5. doi: 10.1016/S0161-6420(98)91224-6.
7
Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.青光眼研究中的大麻素II:不同大麻素对兔眼压的影响。
Curr Eye Res. 1984 Jun;3(6):841-50. doi: 10.3109/02713688409000797.
8
Topical delta 9-tetrahydrocannabinol in hypertensive glaucomas.
J Pharm Pharmacol. 1981 Jan;33(1):40-1. doi: 10.1111/j.2042-7158.1981.tb13699.x.
9
A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol.9-四氢大麻酚和大麻二酚的眼部及中枢效应比较。
J Ocul Pharmacol. 1990 Winter;6(4):259-69. doi: 10.1089/jop.1990.6.259.
10
Effects of a topically applied 2% delta-9-tetrahydrocannabinol ophthalmic solution on intraocular pressure and aqueous humor flow rate in clinically normal dogs.局部应用2% Δ⁹-四氢大麻酚眼药水对临床正常犬眼压和房水流量的影响。
Am J Vet Res. 2013 Feb;74(2):275-80. doi: 10.2460/ajvr.74.2.275.

引用本文的文献

1
Role of Endocannabinoids in Glaucoma: A Review.内源性大麻素在青光眼中的作用:综述
J Curr Glaucoma Pract. 2025 Jan-Mar;19(1):28-37. doi: 10.5005/jp-journals-10078-1467. Epub 2025 Mar 24.
2
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma.大麻素作为治疗青光眼自身免疫性疾病的多靶点药物。
ACS Pharmacol Transl Sci. 2025 Mar 26;8(4):932-950. doi: 10.1021/acsptsci.4c00583. eCollection 2025 Apr 11.
3
Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.
大麻及大麻素对眼部的不良影响与新出现的治疗潜力:一项叙述性综述
Clin Ophthalmol. 2024 Nov 29;18:3529-3556. doi: 10.2147/OPTH.S501494. eCollection 2024.
4
Therapeutic Potential of Cannabinoids in Glaucoma.大麻素在青光眼治疗中的潜在应用
Pharmaceuticals (Basel). 2023 Aug 14;16(8):1149. doi: 10.3390/ph16081149.
5
Cannabinoid-Based Ocular Therapies and Formulations.基于大麻素的眼部治疗方法与制剂
Pharmaceutics. 2023 Mar 27;15(4):1077. doi: 10.3390/pharmaceutics15041077.
6
TFOS lifestyle: Impact of societal challenges on the ocular surface.TFOS 生活方式:社会挑战对眼表的影响。
Ocul Surf. 2023 Apr;28:165-199. doi: 10.1016/j.jtos.2023.04.006. Epub 2023 Apr 14.
7
Immunomodulatory Actions of Cannabinoids: Clinical Correlates and Therapeutic Opportunities for Allergic Inflammation.大麻素的免疫调节作用:变态反应性炎症的临床相关性和治疗机会。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):449-457. doi: 10.1016/j.jaip.2022.10.009. Epub 2022 Oct 22.
8
Newer advances in medical management of glaucoma.青光眼的医学管理新进展。
Indian J Ophthalmol. 2022 Jun;70(6):1920-1930. doi: 10.4103/ijo.IJO_2239_21.
9
The Relationship Between Plasma Tetrahydrocannabinol Levels and Intraocular Pressure in Healthy Adult Subjects.健康成年受试者血浆四氢大麻酚水平与眼压之间的关系
Front Med (Lausanne). 2022 Jan 17;8:736792. doi: 10.3389/fmed.2021.736792. eCollection 2021.
10
Cannabinoids in Glaucoma Patients: The Never-Ending Story.青光眼患者体内的大麻素:永无休止的故事。
J Clin Med. 2020 Dec 8;9(12):3978. doi: 10.3390/jcm9123978.